Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...

Research scientist with the New York State Department of Health (NYSDOH) were out in the field on Monday, sweeping for ticks ...

SmartRent today announced the launch of its strategic value-added reseller program to serve small and mid-market multifamily owners and operators.

During the training and sensitisation programme on emerging vector-borne diseases on Saturday, officials discussed the use of ...

OpenSearch Software Foundation Executive Director Bianca Lewis and Governing Board Chair Carl Meadows on why the new ...

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...

Combat-proven ISR platform will inform future Medium Range Reconnaissance (MRR) program MOORPARK, Calif., April 15, 2026 /PRNewswire/ -- Quantum-Systems Inc., a leader in unmanned intelligence and ...

Researchers have long considered the Stuxnet attacks on Iran's nuclear centrifuges in Natanz to be the opening chapter of ...

The U.S. Army has awarded a $15.3 million contract to German company Quantum Systems for the supply of Vector AI drones to ...

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Defender’s advantage for territory denial: drones alter the ratio of force required to overcome an entrenched defender.